Imexpharm Revenue

In the year 2025, Imexpharm had annual revenue of 2.44T VND with 10.70% growth. Imexpharm had revenue of 640.78B in the quarter ending December 31, 2025, a decrease of -1.73%.

Revenue

2,441.09B

Revenue Growth

+10.70%

P/S Ratio

3.40

Revenue / Employee

1.68B

Employees

1,456

Market Cap

8,301.08B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2,441.09B	235.97B	10.70%
Dec 31, 2024	2,205.12B	211.08B	10.59%
Jan 1, 2024	1,994.04B	350.33B	21.31%
Dec 31, 2022	1,643.71B	377.11B	29.77%
Dec 31, 2021	1,266.60B	-102.83B	-7.51%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Ha Tay Pharmaceutical JSC	2,402.04B
DHG Pharmaceutical JSC	4,983.17B
Binh Dinh Pharmaceutical and Medical Equipment JSC	1,865.23B
Cuu Long Pharmaceutical JSC	1,321.59B
Traphaco JSC	2,651.81B
Domesco Medical Import - Export Joint-Stock	2,078.82B
OPC Pharmaceutical JSC	1,122.99B
Central Pharmaceutical Joint Stock Company No3	438.01B

Revenue Rankings